Tenet Healthcare Corporation (THC)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 3,200,000 | 3,126,000 | 2,755,000 | 2,619,000 | 764,000 | 794,000 | 961,000 | 1,017,000 | 1,000,000 | 975,000 | 1,156,000 | 1,096,000 | 914,000 | 1,079,000 | 434,000 | 403,000 | 399,000 | -13,000 | -49,000 | -120,000 |
| Total stockholders’ equity | US$ in thousands | 4,171,000 | 3,834,000 | 3,475,000 | 3,453,000 | 1,608,000 | 1,464,000 | 1,343,000 | 1,233,000 | 1,142,000 | 1,235,000 | 1,087,000 | 1,056,000 | 1,028,000 | 722,000 | 261,000 | 123,000 | 28,000 | -374,000 | -257,000 | -358,000 |
| ROE | 76.72% | 81.53% | 79.28% | 75.85% | 47.51% | 54.23% | 71.56% | 82.48% | 87.57% | 78.95% | 106.35% | 103.79% | 88.91% | 149.45% | 166.28% | 327.64% | 1,425.00% | — | — | — |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $3,200,000K ÷ $4,171,000K
= 76.72%
Tenet Healthcare Corporation's return on equity (ROE) has shown significant fluctuations over the past few years. The ROE was not provided for the quarters ending in March, June, and September 2020. Starting from December 2020, the ROE was exceptionally high at 1,425.00%, indicating a substantial profitability relative to shareholders' equity.
Subsequently, the ROE experienced a decline but remained elevated at 327.64% in March 2021, signifying sustained profitability. The trend continued with ROE figures of 166.28% in June 2021, 149.45% in September 2021, and 88.91% in December 2021.
From March 2022 to December 2024, the ROE fluctuated within a range, showing figures of 103.79%, 106.35%, 78.95%, 87.57%, 82.48%, 71.56%, 54.23%, and 47.51% up to December 31, 2023. Notably, the ROE experienced an uptick to 75.85% in March 2024, followed by further increases to 79.28% in June 2024, 81.53% in September 2024, and a moderate decline to 76.72% in December 2024.
Overall, Tenet Healthcare Corporation's ROE reflects fluctuations in profitability and efficiency in generating returns for shareholders over the past few years. The corporation should continue monitoring and optimizing its operations to maintain sustainable levels of ROE in the future.
Peer comparison
Dec 31, 2024